$152.50
8.976.25%
Dernière mise à jour: Nov 26, 2:50 PM
Comments
Loading...
Rapport sur les intérêts à découvert
L'intérêt à découvert sur Neurocrine Biosciences Inc (NASDAQ:NBIX) a diminué lors de la dernière période de déclaration, augmentant de en baisse de 4.37M à 4.11M. Cela représente 5.5% des actions disponibles au public de l'entreprise.
Sur la base du volume moyen récent de 1.03M actions échangées par jour, il faudrait 4.01 jour(s) aux détenteurs de cet intérêt à découvert pour clôturer leurs positions sans faire monter brusquement le cours de l'action.
Intérêt à court terme
4.11M
Intérêt à court terme %
5.50%
Jours de couverture
4.01
Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|
NBIX | Neurocrine Biosciences, Inc. C | 10/31/2025 | 11/11/2025 | 5.50% | 74,850,111 | 4,114,577 | 1,026,717 | 4.01 | |
NBIX | Neurocrine Biosciences, Inc. C | 10/15/2025 | 10/24/2025 | 5.88% | 74,325,923 | 4,366,857 | 811,746 | 5.38 | |
NBIX | Neurocrine Biosciences, Inc. C | 09/30/2025 | 10/09/2025 | 5.73% | 74,325,923 | 4,262,521 | 904,194 | 4.71 | |
NBIX | Neurocrine Biosciences, Inc. C | 09/15/2025 | 09/24/2025 | 5.54% | 74,325,923 | 4,119,845 | 830,487 | 4.96 | |
NBIX | Neurocrine Biosciences, Inc. C | 08/29/2025 | 09/10/2025 | 5.56% | 74,325,923 | 4,130,984 | 615,824 | 6.71 | |
NBIX | Neurocrine Biosciences, Inc. C | 08/15/2025 | 08/26/2025 | 5.36% | 74,325,923 | 3,984,398 | 1,010,664 | 3.94 | |
NBIX | Neurocrine Biosciences, Inc. C | 07/31/2025 | 08/11/2025 | 3.84% | 74,325,923 | 2,853,448 | 1,027,016 | 2.78 | |
NBIX | Neurocrine Biosciences, Inc. C | 07/15/2025 | 07/24/2025 | 4.36% | 74,110,233 | 3,234,044 | 795,599 | 4.06 | |
NBIX | Neurocrine Biosciences, Inc. C | 06/30/2025 | 07/10/2025 | 4.77% | 74,110,233 | 3,534,131 | 880,258 | 4.01 | |
NBIX | Neurocrine Biosciences, Inc. C | 06/13/2025 | 06/25/2025 | 4.72% | 74,110,233 | 3,495,103 | 861,233 | 4.06 | |
NBIX | Neurocrine Biosciences, Inc. C | 05/30/2025 | 06/10/2025 | 5.48% | 74,110,233 | 4,064,860 | 1,081,172 | 3.76 | |
NBIX | Neurocrine Biosciences, Inc. C | 05/15/2025 | 05/27/2025 | 5.44% | 74,110,233 | 4,029,414 | 1,984,165 | 2.03 | |
NBIX | Neurocrine Biosciences, Inc. C | 04/30/2025 | 05/09/2025 | 6.05% | 74,110,233 | 4,485,608 | 1,590,320 | 2.82 | |
NBIX | Neurocrine Biosciences, Inc. C | 04/15/2025 | 04/25/2025 | 5.14% | 85,005,508 | 4,370,717 | 1,923,810 | 2.27 | |
NBIX | Neurocrine Biosciences, Inc. C | 03/31/2025 | 04/09/2025 | 4.45% | 85,005,508 | 3,785,885 | 1,102,144 | 3.44 | |
NBIX | Neurocrine Biosciences, Inc. C | 03/14/2025 | 03/25/2025 | 3.87% | 85,005,508 | 3,293,529 | 1,347,686 | 2.44 | |
NBIX | Neurocrine Biosciences, Inc. C | 02/28/2025 | 03/11/2025 | 3.79% | 85,005,508 | 3,225,389 | 1,265,375 | 2.55 | |
NBIX | Neurocrine Biosciences, Inc. C | 02/14/2025 | 02/26/2025 | 3.58% | 85,005,508 | 3,044,928 | 2,139,962 | 1.42 | |
NBIX | Neurocrine Biosciences, Inc. C | 01/31/2025 | 02/11/2025 | 2.78% | 86,548,892 | 2,404,128 | 942,290 | 2.55 | |
NBIX | Neurocrine Biosciences, Inc. C | 01/15/2025 | 01/27/2025 | 3.70% | 86,548,892 | 3,199,103 | 954,772 | 3.35 | |
NBIX | Neurocrine Biosciences, Inc. C | 12/31/2024 | 01/10/2025 | 3.87% | 86,548,892 | 3,349,662 | 1,183,443 | 2.83 | |
NBIX | Neurocrine Biosciences, Inc. C | 12/13/2024 | 12/24/2024 | 3.91% | 86,548,892 | 3,387,745 | 681,921 | 4.97 | |
NBIX | Neurocrine Biosciences, Inc. C | 11/29/2024 | 12/10/2024 | 4.52% | 86,548,892 | 3,909,001 | 1,035,182 | 3.78 | |
NBIX | Neurocrine Biosciences, Inc. C | 11/15/2024 | 11/26/2024 | 4.90% | 86,548,892 | 4,238,364 | 978,467 | 4.33 | |
NBIX | Neurocrine Biosciences, Inc. C | 10/31/2024 | 11/11/2024 | 2.87% | 86,548,892 | 2,480,887 | 976,264 | 2.54 | |
NBIX | Neurocrine Biosciences, Inc. C | 10/15/2024 | 10/24/2024 | 3.03% | 86,278,230 | 2,618,342 | 721,564 | 3.63 | |
NBIX | Neurocrine Biosciences, Inc. C | 09/30/2024 | 10/09/2024 | 2.84% | 86,278,230 | 2,453,813 | 895,875 | 2.74 | |
NBIX | Neurocrine Biosciences, Inc. C | 09/13/2024 | 09/24/2024 | 2.58% | 86,278,230 | 2,227,530 | 1,118,037 | 1.99 | |
NBIX | Neurocrine Biosciences, Inc. C | 08/30/2024 | 09/11/2024 | 2.47% | 86,278,230 | 2,135,372 | 1,142,864 | 1.87 | |
NBIX | Neurocrine Biosciences, Inc. C | 07/31/2024 | 08/09/2024 | 3.10% | 86,278,230 | 2,671,781 | 758,908 | 3.52 | |
NBIX | Neurocrine Biosciences, Inc. C | 07/15/2024 | 07/24/2024 | 3.06% | 85,939,208 | 2,625,574 | 624,257 | 4.21 | |
NBIX | Neurocrine Biosciences, Inc. C | 06/28/2024 | 07/10/2024 | 3.28% | 85,939,208 | 2,817,799 | 1,038,317 | 2.71 | |
NBIX | Neurocrine Biosciences, Inc. C | 06/14/2024 | 06/26/2024 | 2.60% | 85,939,208 | 2,231,985 | 690,814 | 3.23 | |
NBIX | Neurocrine Biosciences, Inc. C | 05/31/2024 | 06/11/2024 | 2.47% | 85,939,208 | 2,125,628 | 798,755 | 2.66 | |
NBIX | Neurocrine Biosciences, Inc. C | 05/15/2024 | 05/24/2024 | 2.16% | 85,939,208 | 1,857,466 | 725,895 | 2.56 | |
NBIX | Neurocrine Biosciences, Inc. C | 04/30/2024 | 05/09/2024 | 2.13% | 85,939,208 | 1,827,288 | 801,194 | 2.28 | |
NBIX | Neurocrine Biosciences, Inc. C | 04/15/2024 | 04/24/2024 | 2.35% | 85,882,478 | 2,021,408 | 714,424 | 2.83 | |
NBIX | Neurocrine Biosciences, Inc. C | 03/28/2024 | 04/09/2024 | 2.82% | 85,882,478 | 2,426,109 | 995,001 | 2.44 | |
NBIX | Neurocrine Biosciences, Inc. C | 03/15/2024 | 03/26/2024 | 2.90% | 85,779,801 | 2,483,716 | 971,474 | 2.56 | |
NBIX | Neurocrine Biosciences, Inc. C | 02/29/2024 | 03/11/2024 | 2.54% | 85,779,801 | 2,176,456 | 843,297 | 2.58 | |
NBIX | Neurocrine Biosciences, Inc. C | 02/15/2024 | 02/27/2024 | 2.54% | 85,779,801 | 2,176,641 | 940,595 | 2.31 | |
NBIX | Neurocrine Biosciences, Inc. C | 01/31/2024 | 02/09/2024 | 2.23% | 84,524,234 | 1,881,406 | 757,138 | 2.48 | |
NBIX | Neurocrine Biosciences, Inc. C | 01/12/2024 | 01/24/2024 | 2.73% | 84,524,234 | 2,310,236 | 658,350 | 3.51 | |
NBIX | Neurocrine Biosciences, Inc. C | 12/29/2023 | 01/10/2024 | 2.68% | 84,524,234 | 2,268,093 | 805,306 | 2.82 | |
NBIX | Neurocrine Biosciences, Inc. C | 12/15/2023 | 12/27/2023 | 2.70% | 84,524,234 | 2,284,971 | 833,226 | 2.74 | |
NBIX | Neurocrine Biosciences, Inc. C | 11/30/2023 | 12/11/2023 | 2.50% | 84,524,234 | 2,112,256 | 635,002 | 3.33 | |
NBIX | Neurocrine Biosciences, Inc. C | 11/15/2023 | 11/27/2023 | 2.70% | 84,524,234 | 2,284,972 | 758,832 | 3.01 |
À la recherche des actions les plus vendues à découvert?